Current Update on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development with a Special Emphasis on Gene Therapy Viral Vector Design and Construction for Vaccination.

Human Gene Therapy
Atil BisginSalih Sanlioglu


Severe acute respiratory syndrome (SARS) is a newly emerging infectious disease (COVID-19) caused by the novel coronavirus SARS-coronavirus 2 (CoV-2). To combat the devastating spread of SARS-CoV-2, extraordinary efforts from numerous laboratories have focused on the development of effective and safe vaccines. Traditional live-attenuated or inactivated viral vaccines are not recommended for immunocompromised patients as the attenuated virus can still cause disease via phenotypic or genotypic reversion. Subunit vaccines require repeated dosing and adjuvant use to be effective, and DNA vaccines exhibit lower immune responses. mRNA vaccines can be highly unstable under physiological conditions. On the contrary, naturally antigenic viral vectors with well-characterized structure and safety profile serve as among the most effective gene carriers to provoke immune response via heterologous gene transfer. Viral vector-based vaccines induce both an effective cellular immune response and a humoral immune response owing to their natural adjuvant properties via transduction of immune cells. Consequently, viral vectored vaccines carrying the SARS-CoV-2 spike protein have recently been generated and successfully used to activate cytotoxic T...Continue Reading


Dec 1, 1993·Biologicals : Journal of the International Association of Biological Standardization·F Horaud
Jun 1, 1996·Nature Medicine·Q Wang, M H Finer
Sep 12, 1998·Journal of Virology·H MiyoshiI M Verma
Oct 10, 1998·Journal of Virology·T DullL Naldini
Jun 7, 2000·Proceedings of the National Academy of Sciences of the United States of America·Z YanJ F Engelhardt
Aug 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·T S GriffithT L Ratliff
Sep 8, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·T S Griffith, E L Broghammer
Jul 12, 2002·Current Gene Therapy·S SanliogluJ F Engelhardt
Nov 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kevin DoerschugGary W Hunninghake
Jan 14, 2003·Revue Scientifique Et Technique·S J Barteling
Apr 16, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ahter D SanliogluSalih Sanlioglu
Apr 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Himani BishtBernard Moss
Mar 12, 2005·Human Gene Therapy·Dan H Barouch, Gary J Nabel
Jul 19, 2005·Emerging Infectious Diseases·Shibo JiangShuwen Liu
Jan 21, 2006·Cancer Research·Laurence ChapatteFrédéric Lévy
Oct 30, 2007·Nature Reviews. Microbiology·Konstantin ChumakovVadim I Agol
Jan 16, 2008·The Journal of Experimental Medicine·Rafick-Pierre Sekaly
Aug 7, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Douglas M McCarty
Sep 18, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Katalin KarikóDrew Weissman
Oct 16, 2008·Clinical Microbiology Reviews·Shyam Daya, Kenneth I Berns

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.